The present invention relates to a high affinity monoclonal antibody and to an enzyme immunoassay of human G-CSF using the antibody. The trace amount of human G-CSF in samples such as body fluids from patients with hematological disorders can be measured without interference in the body fluids. For example, the measurable human G-CSF concentration in plasma is 0.5 pg/ml in minimum.